Table 2 Baseline levels of blood biomarkers in non-survivors and survivors for patients with SJS-ILD.

From: Blood KL-6 predicts prognosis in primary Sjögren’s syndrome-associated interstitial lung disease

Characteristics

Total

Non-survivors

Survivors

P value

KL-6 (pg/mL)

75.2 ± 116.0

119.6 ± 124.0

59.5 ± 110.7

0.037

CCL18 (ng/mL)

63.8 ± 31.6

66.1 ± 23.6

62.9 ± 34.3

0.484

YKL-40 (ng/mL)

114.1 ± 131.3

187.4 ± 206.9

88.2 ± 81.2

0.147

IL-4Ra (ng/mL)

2.2 ± 4.3

0.5 ± 1.6

2.8 ± 4.8

0.053

MMP-7 (ng/mL)

2.6 ± 2.3

3.6 ± 1.7

2.2 ± 2.4

0.072

  1. Data are presented as mean ± standard deviation or number (%), unless otherwise indicated.
  2. CCL18 CC chemokine ligand 18, IL-4Ra interleukin-4 receptor alpha, ILD interstitial lung disease, KL-6 Krebs von den Lungen-6, MMP-7 matrix metalloproteinase-7, SJS Sjögren syndrome, YKL-40 chitinase-3-like-1.
Back to article page